Insider · CIK 0001458190
Robert J Michel
Files at DXR (DAXOR CORP), BKYI (BIO KEY INTERNATIONAL INC). First filing Mar 11, 2025, latest Mar 31, 2026.
Robert J Michel files SEC Form 4 as director and CFO at DXR (DAXOR CORP), and also at BKYI (BIO KEY INTERNATIONAL INC). Since Mar 11, 2025, Robert J Michel has reported 2 open-market buys worth $18k and 0 open-market sells worth $0, the latest filed on Mar 31, 2026.
A track record needs three past buys with six months of prices behind them; Robert J Michel has 0, so none is measured yet.
The newest scored trade: bought $9,900 of DXR on Mar 31, 2026, filed Mar 31, 2026, scored 38 (weak). In the last 12 months: 1 buy worth $9,900 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DXR: DAXOR CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | DAXOR CORP | $9,900 1,000 shares | +5% | +34% from low-34% from high | |
| 33Weak | DAXOR CORP | $8,000 1,000 shares | +6% | - |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | DXR DAXOR CORP | AGrant or award Daxor Common Stock | +12,000 | $0.00 | $0 | 33,050 | Jun 25, 2026 |
| Mar 31, 2026 | DXR DAXOR CORP | POpen-market purchase Daxor Common Stock | +1,000 | $9.90 | $9,900 | 21,050 | Mar 31, 2026 |
| Dec 9, 2025 | DXR DAXOR CORP | POpen-market purchase Daxor Common Stock | +3,000 | $0.00 | $0 | 20,050 | Dec 11, 2025 |
| May 27, 2025 | BKYI BIO KEY INTERNATIONAL INC | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 22,303 | May 27, 2025 |
| May 27, 2025 | BKYI BIO KEY INTERNATIONAL INC | AGrant or award Common Stock | +1,266 | $0.79 | $1,000 | 23,569 | May 27, 2025 |
| May 8, 2025 | BKYI BIO KEY INTERNATIONAL INC | AGrant or award Common Stock | +3,897 | $0.00 | $0 | 17,303 | May 12, 2025 |
| Mar 20, 2025 | BKYI BIO KEY INTERNATIONAL INC | AGrant or award Common Stock | +2,971 | $0.00 | $0 | 13,406 | Mar 21, 2025 |
| Mar 10, 2025 | DXR DAXOR CORP | POpen-market purchase Daxor Common Stock | +1,000 | $8.00 | $8,000 | 17,050 | Mar 11, 2025 |
| Mar 27, 2023 | DXR DAXOR CORP | POpen-market purchase Daxor Common Stock | +4,750 | $0.00 | $0 | 15,050 | Dec 10, 2024 |
| Nov 7, 2024 | BKYI BIO KEY INTERNATIONAL INC | AGrant or award Common Stock | +2,587 | $0.00 | $0 | 10,435 | Nov 8, 2024 |
Questions about Robert J Michel
Answered from the filings on this page, as of the latest one.
Is Robert J Michel buying or selling?
In the last 12 months Robert J Michel reported 1 open-market buy worth $9,900 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $9,900 of DXR on Mar 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Robert J Michel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert J Michel has 0.
Where does Robert J Michel file Form 4?
Robert J Michel has filed Form 4 at DXR (DAXOR CORP) as Chief Financial Officer; BKYI (BIO KEY INTERNATIONAL INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.